# Metoclopramide, Azithromycin, or Nondrug Pretreatment for UGIB to Reduce Second Endoscopy

> **NCT03840057** · PHASE2 · UNKNOWN · sponsor: **Waihong Chung** · enrollment: 435 (estimated)

## Conditions studied

- Gastro Intestinal Bleeding
- Upper Gastrointestinal Bleeding

## Interventions

- **DRUG:** Azithromycin Injection
- **DRUG:** Metoclopramide Injectable Solution
- **DRUG:** Sodium chloride 0.9%

## Key facts

- **NCT ID:** NCT03840057
- **Lead sponsor:** Waihong Chung
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-07-01
- **Primary completion:** 2021-06
- **Final completion:** 2021-07
- **Target enrollment:** 435 (ESTIMATED)
- **Last updated:** 2020-08-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03840057

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03840057, "Metoclopramide, Azithromycin, or Nondrug Pretreatment for UGIB to Reduce Second Endoscopy". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03840057. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*